3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Anus Neoplasms
2
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Squamous Intraepithelial Lesions
1
Sleep Apnea, Obstructive
1
Sarcoma
1
Rectal Neoplasms
1
Precancerous Conditions
1
Polycythemia Vera
1
Pneumonia
1
Pancreatic Neoplasms
1
Pain
1
Osteoporosis
1
Oropharyngeal Neoplasms
1
Obesity
1
Mouth Neoplasms
1
Lung Diseases, Interstitial
1
Leukemia, B-Cell
1
Hypertension
1
Hypercholesterolemia
1
Homosexuality
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Interventions
Cisplatin
11
Cetuximab
10
Radiotherapy
7
Fluorouracil
6
Docetaxel
5
pembrolizumab
4
Carboplatin
4
figitumumab
3
Radiation
3
Paclitaxel
3
Erlotinib Hydrochloride
3
Bleomycin
3
130-nm albumin-bound paclitaxel
3
talimogene laherparepvec
2
avelumab
2
Surgical Procedures, Operative
2
Oxaliplatin
2
Lapatinib
2
Capecitabine
2
zalutumumab
1
yeast-CEA vaccine
1
temsirolimus
1
temoporfin
1
smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic
1
selinexor
1
remetinostat
1
ponatinib
1
patritumab
1
nilotinib
1
necitumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma, Squamous Cell
×
Observation
×
Clear all
NCT02503111
2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA
Terminated
71 enrolled